Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
View Patent ↗A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.
1. A composition comprising chromium bound to niacin and three compounds selected from the group consisting of (−) hydroxycitric acid, zinc, trans-resveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek.
2. A composition as defined in claim 1 , wherein the composition further comprises between about 50 and about 1,000 μg chromium bound to niacin.
3. A composition as defined in claim 1 , wherein the composition further comprises between about 250 and about 3,000 mg (−)hydroxycitric acid.
4. A composition as defined in claim 1 , wherein the composition further comprises between about 5 and about 50 mg zinc.
5. A composition as defined in claim 1 , wherein the composition further comprises between about 5 and about 100 mg trans-resveratrol.
6. A composition as defined in claim 1 , wherein the composition further comprises between about 50 and about 200 mg gymnemic acid.
7. A composition as defined in claim 1 , wherein the composition further comprises between about 0.025 and about 0.1 mg selenium.
8. A composition as defined in claim 1 , wherein the composition further comprises between about 5 and about 100 mg of an anthocyanidin.
9. A composition as defined in claim 1 , wherein the composition further comprises between about 2 and about 8 mg allicin.
10. A composition as defined in claim 1 , wherein the composition further comprises between about 100 and about 300 mg of fenugreek.